Reduction of Recurrent Strokes in Patients with PFO: Long-Term Outcomes
In this scientific session from SCAI 2021 Matthew Price, M.D. and Robert Sommer, M.D. discuss the REDUCE extended follow-up with a median of five years, PFO closure strategies leveraging the REDUCE data, and explore the next frontier in patient analysis.
Comments 0
Login to view comments.
Click here to Login
